Danés I - Search Results

1

Safety of Drugs Used during the First Wave of COVID-19: A Hospital-Registry-Based Study.

Aguilera C, Danés I, Guillén E, Vimes A, Bosch M, Cereza G, Sánchez-Montalvá A, Campos-Varela I, Miarons M, Mestre-Torres J, Agustí A. Aguilera C, et al. Among authors: danes i. Diagnostics (Basel). 2022 Jul 1;12(7):1612. doi: 10.3390/diagnostics12071612. Diagnostics (Basel). 2022. PMID: 35885517 Free PMC article.

2

An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians: a time series analysis in Spain.

Pedrós C, Vallano A, Cereza G, Mendoza-Aran G, Agustí A, Aguilera C, Danés I, Vidal X, Arnau JM. Pedrós C, et al. Among authors: danes i. Drug Saf. 2009;32(1):77-83. doi: 10.2165/00002018-200932010-00007. Drug Saf. 2009. PMID: 19132807

3

Effect of an intervention on the features of adverse drug reactions spontaneously reported in a hospital.

Cereza G, Agustí A, Pedrós C, Vallano A, Aguilera C, Danés I, Vidal X, Arnau JM. Cereza G, et al. Among authors: danes i. Eur J Clin Pharmacol. 2010 Sep;66(9):937-45. doi: 10.1007/s00228-010-0856-8. Epub 2010 Jun 16. Eur J Clin Pharmacol. 2010. PMID: 20552176

4

Educational sessions in pharmacovigilance: What do the doctors think?

Vallano A, Pedrós C, Agustí A, Cereza G, Danés I, Aguilera C, Arnau JM. Vallano A, et al. Among authors: danes i. BMC Res Notes. 2010 Nov 17;3:311. doi: 10.1186/1756-0500-3-311. BMC Res Notes. 2010. PMID: 21083899 Free PMC article.

5

A case series of confusional states and other neurotoxic effects caused by ertapenem.

Danés I, Pérez E, Pigrau C, Gracia RM, Perelló M, Sueiras M, Aguilera C, Agustí A. Danés I, et al. Br J Clin Pharmacol. 2021 Apr;87(4):2140-2145. doi: 10.1111/bcp.14582. Epub 2020 Nov 3. Br J Clin Pharmacol. 2021. PMID: 33010054 Free article.

6

Withdrawal of hospital outpatient treatments in severe diseases due to unacceptable toxicity: A retrospective study from the register of patients and treatments.

Agustí A, Aguilera C, Bosch M, Danés I, Pérez E, Vendrell L, Aller MB, Boixareu N, García-Doladé N, Diogène E. Agustí A, et al. Among authors: danes i. Br J Clin Pharmacol. 2021 Jun;87(6):2549-2557. doi: 10.1111/bcp.14665. Epub 2020 Dec 3. Br J Clin Pharmacol. 2021. PMID: 33216993 Free article.

7

Adverse Reactions to Drugs of Special Interest in a Pediatric Oncohematology Service.

Amaro-Hosey K, Danés I, Vendrell L, Alonso L, Renedo B, Gros L, Vidal X, Cereza G, Agustí A. Amaro-Hosey K, et al. Among authors: danes i. Front Pharmacol. 2021 May 5;12:670945. doi: 10.3389/fphar.2021.670945. eCollection 2021. Front Pharmacol. 2021. PMID: 34025429 Free PMC article.

8

Spontaneously Reported Adverse Drug Reactions and Their Description in Hospital Discharge Reports: A Retrospective Study.

Aguilera C, Agustí A, Pérez E, Gracia RM, Diogène E, Danés I. Aguilera C, et al. Among authors: danes i. J Clin Med. 2021 Jul 26;10(15):3293. doi: 10.3390/jcm10153293. J Clin Med. 2021. PMID: 34362076 Free PMC article.

9

Off-Label Use of Rituximab in Patients with Different Types of Nephropathies in a Tertiary Hospital: A Retrospective Study.

Sans-Pola C, Agustí A, Bosch JÀ, Agraz I, Alerany C, Danés I. Sans-Pola C, et al. Among authors: danes i. J Clin Med. 2021 Oct 26;10(21):4941. doi: 10.3390/jcm10214941. J Clin Med. 2021. PMID: 34768461 Free PMC article.

10

Adverse Drug Reactions in Pediatric Oncohematology: A Systematic Review.

Amaro-Hosey K, Danés I, Agustí A. Amaro-Hosey K, et al. Among authors: danes i. Front Pharmacol. 2022 Feb 3;12:777498. doi: 10.3389/fphar.2021.777498. eCollection 2021. Front Pharmacol. 2022. PMID: 35185536 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page